相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Real-world experience with pasireotide-LAR in resistant acromegaly: a single center 1-year observation
Maria Stelmachowska-Banas et al.
PITUITARY (2022)
Diabetes Mellitus Predicts Weight Gain After Surgery in Patients With Acromegaly
Han Na Jang et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Effect of Diabetes on Morbidity and Mortality in Patients With Acromegaly
Daniela Esposito et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2022)
Acromegaly: pathogenesis, diagnosis, and management
Maria Fleseriu et al.
LANCET DIABETES & ENDOCRINOLOGY (2022)
HOMA-IR in acromegaly: a systematic review and meta-analysis
Betina Biagetti et al.
PITUITARY (2021)
Possible protective role of metformin therapy on colonic polyps in acromegaly: an exploratory cross-sectional study
M Albertelli et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)
Prevalence and outcome of comorbidities associated with acromegaly
Sven Berkmann et al.
ACTA NEUROCHIRURGICA (2021)
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study
Susan L. Samson et al.
PITUITARY (2021)
Sodium glucose cotransporter 2 inhibitors treatment in acromegalic patients with diabetes-a case series and literature review
Adnan Zaina et al.
ENDOCRINE (2021)
Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review study
A. Colao et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)
Clinical features and therapeutic outcomes of patients with acromegaly in Saudi Arabia: a retrospective analysis
Mussa Hussain AlMalki et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2020)
Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs
Monica Gadelha et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Drug treatment strategies for secondary diabetes in patients with acromegaly
Sylvere Stoermann et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
Mechanisms of putative IGF-I receptor resistance in active acromegaly
Joseph A. M. J. L. Janssen
GROWTH HORMONE & IGF RESEARCH (2020)
Risk factors and management of pasireotide-associated hyperglycemia in acromegaly
Monica R. Gadelha et al.
ENDOCRINE CONNECTIONS (2020)
Acromegaly
Annamaria Colao et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Correlation analysis between short-term insulin-like growth factor-I and glucose intolerance status after transsphenoidal adenomectomy in acromegalic patients: a large retrospective study from a single center in China
Yi-Lin Li et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2019)
Correlations of clinical parameters with quality of life in patients with acromegaly: Taiwan Acromegaly Registry
Fen-Yu Tseng et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)
Glucose Abnormalities Associated to Prolactin Secreting Pituitary Adenomas
Renata S. Auriemma et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Total adiponectin in overweight and obese subjects and its response to visceral fat loss
Salah Gariballa et al.
BMC ENDOCRINE DISORDERS (2019)
Glucose-dependent Insulinotropic Polypeptide (GIP) Resistance and β-cell Dysfunction Contribute to Hyperglycaemia in Acromegaly
Vikram Singh Shekhawat et al.
SCIENTIFIC REPORTS (2019)
Disposition Index in Active Acromegaly
Dan Alexandru Niculescu et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Preoperative Fasting C-Peptide Acts as a Promising Predictor of Improved Glucose Tolerance in Patients With Acromegaly After Transsphenoidal Surgery: A Retrospective Study of 64 Cases From a Large Pituitary Center in China
Zihao Wang et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Sodium Glucose Co-transporter Inhibitors in Patients with Acromegaly and Diabetes
Zaina Adnan
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Surgical outcomes and predictors of glucose metabolism alterations for growth hormone-secreting pituitary adenomas: a hospital-based study of 151 cases
Wenqiang He et al.
ENDOCRINE (2019)
Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy
Thierry Brue et al.
ENDOCRINE (2019)
Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study)
Ammar Muhammad et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly
Baldomero Gonzalez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Understanding the tissue-specific roles of IGF1/IGF1R in regulating metabolism using the Cre/loxP system
Rhonda D. Kineman et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study
Ming Shen et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
Insulin-Like Growth Factor-1 at Diagnosis and during Subsequent Years in Adolescents with Type 1 Diabetes
Simona I. Chisalita et al.
JOURNAL OF DIABETES RESEARCH (2018)
Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database
Federico Gatto et al.
ENDOCRINE (2018)
Marked alteration of glycemic profile surrounding lanreotide administration in acromegaly: A case report
Sho Tanaka et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study
Eva Lesen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) Database
Patrick Petrossians et al.
ENDOCRINE-RELATED CANCER (2017)
Rapid Onset of Diabetic Ketoacidosis After SGLT2 Inhibition in a Patient With Unrecognized Acromegaly
Marino Quarella et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Diabetic ketoacidosis in acromegaly; a rare complication precipitated by corticosteroid use
Jeremy Weiss et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Effect of AP102, a subtype 2 and 5 specific somatostatin analog, on glucose metabolism in rats
Erika Tarasco et al.
ENDOCRINE (2017)
Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study
Shigeyuki Tahara et al.
ENDOCRINE JOURNAL (2017)
Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
I. Bernabeu et al.
PITUITARY (2016)
Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly
M. G. Baroni et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
The modulation of adiponectin by STAT5-activating hormones
Ursula A. White et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study
Jakob Dal et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
The influence of type 2 diabetes on serum GH and IGF-I levels in hospitalized Japanese patients
Kentaro Suda et al.
GROWTH HORMONE & IGF RESEARCH (2016)
Despite higher body fat content, Ecuadorian subjects with Laron syndrome have less insulin resistance and lower incidence of diabetes than their relatives
Jaime Guevara-Aguirre et al.
GROWTH HORMONE & IGF RESEARCH (2016)
Dopaminergic drugs in type 2 diabetes and glucose homeostasis
Felicitas Lopez Vicchi et al.
PHARMACOLOGICAL RESEARCH (2016)
Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center
Babak Torabi Sagvand et al.
PITUITARY (2016)
The Impact of Adipose Tissue on Insulin Resistance in Acromegaly
Nicoleta Cristina Olarescu et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Current and Emerging Aspects of Diabetes Mellitus in Acromegaly
Stefano Frara et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study
Marcello D. Bronstein et al.
BMC ENDOCRINE DISORDERS (2016)
The prevalence of acromegaly in hospitalized patients with type 2 diabetes
Kentaro Suda et al.
ENDOCRINE JOURNAL (2015)
Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations
A. Ciresi et al.
GROWTH HORMONE & IGF RESEARCH (2015)
Adipose Tissue Redistribution and Ectopic Lipid Deposition in Active Acromegaly and Effects of Surgical Treatment
Carlos M. Reyes-Vidal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
GH Receptor Deficiency in Ecuadorian Adults Is Associated With Obesity and Enhanced Insulin Sensitivity
Jaime Guevara-Aguirre et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
The Role of Diabetes in Acromegaly Associated Neoplasia
Sonia Cheng et al.
PLOS ONE (2015)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2014)
Therapy of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to normalise IGF1 levels
Michael Droste et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors
Andrea Giustina et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
A. Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients
Orsalia Alexopoulou et al.
PITUITARY (2014)
Clinical features and therapeutic outcomes of acromegaly during the recent 10 years in a single institution in Japan
Izumi Fukuda et al.
PITUITARY (2014)
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
Monica R. Gadelha et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Prevalence of diabetes mellitus in patients with acromegaly
A. V. Dreval et al.
ENDOCRINE CONNECTIONS (2014)
Suppression of Primary Aldosteronism and Resistant Hypertension by the Peroxisome Proliferator-activated Receptor Gamma Agonist Pioglitazone
Yusuke Kashiwagi et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2013)
Emerging trends in the diagnosis and treatment of acromegaly in Canada
Sophie Vallette et al.
CLINICAL ENDOCRINOLOGY (2013)
Ketoacidosis as the initial clinical condition in nine patients with acromegaly: a review of 860 cases at a single institute
Naohiro Yoshida et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
The Metabolic Profile in Active Acromegaly is Gender-Specific
A. Ciresi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
Robert R. Henry et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly
Dan Niculescu et al.
PITUITARY (2013)
Diabetic Ketoacidosis in Acromegaly: A Case Report
Pilaiporn Palakawong et al.
Endocrine Practice (2012)
Adipocytes as a Source of Increased Circulating Levels of Nicotinamide Phosphoribosyltransferase/Visfatin in Active Acromegaly
Nicoleta C. Olarescu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotide
Elisabeth Couture et al.
PITUITARY (2012)
Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry
Sandrine Fieffe et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population
Pedro Weslley Rosario
PITUITARY (2011)
Influence of diabetes mellitus on vertebral fractures in men with acromegaly
Gherardo Mazziotti et al.
ENDOCRINE (2011)
The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment
J. Roemmler et al.
GROWTH HORMONE & IGF RESEARCH (2010)
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Niels Moller et al.
ENDOCRINE REVIEWS (2009)
Glucose Tolerance and Somatostatin Analog Treatment in Acromegaly: A 12-Month Study
Annamaria Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Pegvisomant Improves Insulin Sensitivity and Reduces Overnight Free Fatty Acid Concentrations in Patients with Acromegaly
C. E. Higham et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
Gherardo Mazziotti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly
Hidenori Fukuoka et al.
HORMONE RESEARCH (2008)
Comparison of pancreas-transplanted type 1 diabetic patients with portal-venous versus systemic-venous graft drainage:: Impact on glucose regulatory hormones and the growth hormone/insulin-like growth factor-I axis
Jan Frystyk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly
Pamela U. Freda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Reduced Basal ATP Synthetic Flux of Skeletal Muscle in Patients with Previous Acromegaly
Julia Szendroedi et al.
PLOS ONE (2008)
Acromegaly associated with type 2 diabetes showing normal IGF-1 levels under poorly controlled glycemia
Dong Jun Lim et al.
ENDOCRINE JOURNAL (2007)
Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women
Jeanine B. Albu et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2007)
Growth hormone regulation of p85α expression and phosphoinositide 3-kinase activity in adipose tissue -: Mechanism for growth hormone-mediated insulin resistance
Juan-Pablo del Rincon et al.
DIABETES (2007)
Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic women
JB Albu et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2005)
Effect of pituitary surgery in patients with acromegaly on adiponectin serum concentrations and alanine aminotransferase activity
P Wiesli et al.
CLINICA CHIMICA ACTA (2005)
Effects of growth hormone on the function of β-adrenoceptor subtypes in rat adipocytes
SM Yang et al.
OBESITY RESEARCH (2004)
A case of secondary diabetes mellitus with acromegaly improved by pioglitazone
A Watanabe et al.
DIABETIC MEDICINE (2004)
Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice
S Yakar et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
PPAR-γ receptor ligands:: novel therapy for pituitary adenomas
AP Heaney et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor
SH Xuan et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue
CM Halleux et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Risk factors for glucose intolerance in active acromegaly
A Kreze et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2001)
Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure
S Nielsen et al.
DIABETES (2001)
Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity
S Yakar et al.
DIABETES (2001)
Regulation of β-cell mass by hormones and growth factors
JH Nielsen et al.
DIABETES (2001)
Bromocriptine - A novel approach to the treatment of type 2 diabetes
H Pijl et al.
DIABETES CARE (2000)
分享论文
